FZU-79429-05858
4 vaccinations
11 coded responses
37 check-ins
11 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 112 / NY
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
-
2021-03-31
Survey response — days 1–6 daily, dose 1MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Metallic taste in mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 1MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Metallic taste in my mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
- 2021-04-04
- 2021-04-05
- 2021-04-08
- 2021-04-13
-
2021-04-20
Dose 2 — Pfizer-BioNTech
- 2021-04-20
-
2021-04-21
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations — Feeling: Poor · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: PalpitationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain, Itching · Fever · Fatigue or tirednessFree text: Light sweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Lymph node pain — Feeling: Good · Site: PainFree text: Tender lymph node in armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-29
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
-
2021-06-01
Survey response — day 42, dose 2MedDRA: Hypomenorrhoea, Intermenstrual bleeding — Feeling: GoodFree text: Lighter than usual menstrual cycle, followed by spotting a week later.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-20
- 2021-10-19
-
2021-11-26
Dose 3 — Moderna
- 2022-04-20
-
2022-05-29
Survey response — 6 months, dose 3MedDRA: Menstruation irregular — Feeling: GoodFree text: Irregular menstruationMedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Dose 4 — Moderna
-
2022-10-09
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-10-10
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-11
Survey response — days 1–6 daily, dose 4MedDRA: Brain fog — Feeling: Fair · Fatigue or tirednessFree text: Brain fogMedDRA releases: 2024-11 · check-in free text available
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-21
-
2022-10-28
Survey response — day 21, dose 4MedDRA: Diarrhoea — Feeling: FairFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
-
2022-11-06
Survey response — day 28, dose 4MedDRA: Cough, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cough, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Survey response — day 35, dose 4MedDRA: Cough, Fatigue, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion, cough, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-11-20
- 2023-01-06
- 2023-04-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-11-26 | Moderna | No |
| 4 | 2022-10-07 | Moderna | No |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Metallic taste in mouth
Systemic reaction (other): Metallic taste in my mouth
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Palpitations
Systemic reaction (other): Light sweating
Systemic reaction (other): Tender lymph node in armpit
Release 8 — day 42, dose 2
Symptoms: Lighter than usual menstrual cycle, followed by spotting a week later.
Release 11 — 6 months, dose 3
Symptoms: Irregular menstruation
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Brain fog
Release 12 — day 21, dose 4
Symptoms: Diarrhea
Release 12 — day 28, dose 4
Symptoms: Cough, fatigue
Release 12 — day 35, dose 4
Symptoms: Congestion, cough, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypomenorrhoea | ✓ | ✓ | ✓ |
| SD | Intermenstrual bleeding | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ○ |
| SRO | Brain fog | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release